Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin: fluorescein angiographic guidelines for evaluation and treatment--TAP and VIP report No. 2.
暂无分享,去创建一个
Irene Barbazetto | Neil M Bressler | Susan B Bressler | Laurie Haynes | N. Bressler | S. Bressler | M. Potter | A. Reaves | P. Rosenfeld | A. Schachat | I. Barbazetto | Amy Burdan | Al Reaves | H Andrew Strong | A. Kapetanios | Philip Rosenfeld | Karl Olsen | Anastasios D Kapetanios | Julius Lukas | Michael Potter | Andrew P Schachat | Andrea Wenkstern | A. Burdan | J. Lukas | K. Olsen | H. A. Strong | A. Wenkstern | Laurie A Haynes
[1] Photodynamic therapy with verteporfin for choroidal neovascularization in patients with diabetic retinopathy. , 2001, American journal of ophthalmology.
[2] George A. Williams,et al. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial--VIP report no. 1. , 2001, Ophthalmology.
[3] J. R. Landis,et al. The measurement of observer agreement for categorical data. , 1977, Biometrics.
[4] G Soubrane,et al. Occult subretinal new vessels in age-related macular degeneration. Natural History and early laser treatment. , 1990, Ophthalmology.
[5] Verteporfin Roundtable Participants. GUIDELINES FOR USING VERTEPORFIN (VISUDYNE®) IN PHOTODYNAMIC THERAPY TO TREAT CHOROIDAL NEOVASCULARIZATION DUE TO AGE-RELATED MACULAR DEGENERATION AND OTHER CAUSES , 2002, Retina.
[7] Subfoveal neovascular lesions in age-related macular degeneration. Guidelines for evaluation and treatment in the macular photocoagulation study. Macular Photocoagulation Study Group. , 1991, Archives of ophthalmology.
[8] N. Bressler,et al. The use of fundus photographs and fluorescein angiograms in the identification and treatment of choroidal neovascularization in the Macular Photocoagulation Study. The Macular Photocoagulation Study Group. , 1989, Ophthalmology.
[9] N. Bressler. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2. , 2002, American journal of ophthalmology.